A Study of MG-K10 in Subjects With Asthma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study is a phase Ib/II clinical trial conducted in Chinese adult asthmatic subjects to evaluate the preliminary efficacy and safety of MG-K10 humanized monoclonal antibody injection in the treatment of asthma.
Epistemonikos ID: a8362ed1ed9f85caec447895aea6626d12fcd0ee
First added on: May 13, 2024